SUPPLEMENTAL INDENTURESupplemental Indenture • November 29th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 29th, 2016 Company Industry JurisdictionThis Supplemental Indenture (this “Supplemental Indenture”) is dated as of November 29, 2016, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as Trustee (the “Trustee”).